Blepharospasm (diagnosis) < Blepharospasm (drug therapy) < Blepharospasm (epidemiology)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 33.
[0-20] [0 - 20][0 - 33][20-32][20-40]

Ident.	Authors (with country if any)	Title
000166 (1999)	T. Mezaki [Japon] ; R. Kaji ; M F Brin ; M. Hirota-Katayama ; T. Kubori ; T. Shimizu ; J. Kimura	Combined use of type A and F botulinum toxins for blepharospasm: a double-blind controlled trial.
000707 (2002)	Alfredo Berardelli [Italie] ; Antonio Curra	Pathophysiology and treatment of cranial dystonia.
000921 (2002)	Brad A. Racette [États-Unis] ; Mikula Stambuk ; Joel S. Perlmutter	Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024).
000B76 (2003)	Roy R. Reeves [États-Unis] ; Vincent Liberto	Treatment of essential blepharospasm with quetiapine.
000D82 (2004)	Cristina Sampaio [Portugal] ; João Costa ; Joaquim J. Ferreira	Clinical comparability of marketed formulations of botulinum toxin.
000F07 (2004)	Nélida Susana Garretto [Argentine] ; José A. Bueri ; Roberto D. Rey ; Tomoko Arakaki ; Gabriela V. Nano ; Marcela Mancuso	Improvement of blepharospasm with Zolpidem.
001189 (2005)	Takahiro Mezaki ; Rie Sakai	Botulinum toxin and skin rash reaction.
001216 (2005)	Albert Marchetti [États-Unis] ; Raf Magar ; Leslie Findley ; Jan P. Larsen ; Zvezdan Pirtosek ; Evzen Růzicka ; Evzen R Uzizka ; Robert Jech ; Jaroslaw Sławek ; Fayyaz Ahmed	Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study.
001347 (2005)	Suresh Sagili ; Raman Malhotra ; John Elston	Facial palsy-induced blepharospasm relieved by a Bangerter foil.
001830 (2006)	Giovanni Cossu [Italie] ; Alessandra Mereu ; Marcello Deriu ; Maurizio Melis ; Andrea Molari ; Giannina Melis ; Laura Minafra ; Tiziana Pisano ; Carlo Cianchetti ; Enzo Ortu ; Gianfranco Sau ; Isidoro Aiello ; Miriana Fresu ; Maria Giovanna Marrosu ; Paolo Contu	Prevalence of primary blepharospasm in Sardinia, Italy: a service-based survey.
001999 (2007)	Jörg Müller [Autriche] ; Martina Rinnerthaler ; Werner Poewe [Autriche] ; Markus Kofler	Auditory startle reaction in primary blepharospasm.
001B74 (2007)	Mark Obermann [Allemagne] ; Ozguer Yaldizli ; Armin De Greiff ; Martin Lenard Lachenmayer ; Anna Rebecca Buhl ; Felicitus Tumczak ; Elke Ruth Gizewski ; Hans-Christoph Diener ; Matthias Maschke	Morphometric changes of sensorimotor structures in focal dystonia.
001B94 (2007)	Kenju Hara ; Akiko Matsuda ; Yuko Kitsukawa ; Keiko Tanaka ; Masatoyo Nishizawa ; Asako Tagawa	Botulinum toxin treatment for blepharospasm associated with myasthenia gravis.
001F03 (2008)	Tetsuya Takahashi ; Tetsuhito Murata ; Yuji Wada	Successful treatment of blepharospasm with tandospirone, a 5-HT1A partial agonist: a case report.
002448 (2009)	Joseph Jankovic [États-Unis] ; Christopher Kenney ; Susanne Grafe ; Roman Goertelmeyer ; George Comes	Relationship between various clinical outcome assessments in patients with blepharospasm.
002710 (2009)	Irene Martinez-Torres ; Patricia Limousin ; Steve Tisch ; Rupert Page ; Ashwin Pinto ; Thomas Foltynie ; Kailash P. Bhatia ; Marwan I. Hariz ; Ludvic Zrinzo	Early and marked benefit with GPi DBS for Lubag syndrome presenting with rapidly progressive life-threatening dystonia.
003178 (2011)	Joseph Jankovic [États-Unis] ; Cynthia Comella ; Angelika Hanschmann ; Susanne Grafe	Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial.
004673 (1987)	M F Brin [États-Unis] ; S. Fahn ; C. Moskowitz ; A. Friedman ; H M Shale ; P E Greene ; A. Blitzer ; T. List ; D. Lange ; R E Lovelace	Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
004681 (1987)	Joseph Jankovic [États-Unis] ; B M Patten	Blepharospasm and autoimmune diseases.
004696 (1995)	R. Lindeboom [Pays-Bas] ; R. De Haan ; M. Aramideh ; J D Speelman	The blepharospasm disability scale: an instrument for the assessment of functional health in blepharospasm.
004714 (1995)	V. Lepore [Italie] ; G. Defazio ; D. Acquistapace ; C. Melpignano ; L. Pomes ; P. Lamberti ; P. Livrea ; E. Ferrari	Botulinum A toxin for the so-called apraxia of lid opening.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Blepharospasm (drug therapy)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Blepharospasm (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Blepharospasm (drug therapy)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024